(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202406 | 202306 | % Var | 202406 | 202306 | % Var | 202403 | 202303 | % Var | |
| Sales | 41676.30 | 34956.40 | 19.22 | 41676.30 | 34956.40 | 19.22 | 146665.00 | 112588.30 | 30.27 |
| Other Income | 390.80 | 277.40 | 40.88 | 390.80 | 277.40 | 40.88 | 1067.30 | 912.60 | 16.95 |
| PBIDT | 12378.90 | 7327.60 | 68.94 | 12378.90 | 7327.60 | 68.94 | 35657.90 | 11739.20 | 203.75 |
| Interest | 135.50 | 161.80 | -16.25 | 135.50 | 161.80 | -16.25 | 563.50 | 984.40 | -42.76 |
| PBDT | 12243.40 | 7165.80 | 70.86 | 12243.40 | 7165.80 | 70.86 | 35094.40 | 10754.80 | 226.31 |
| Depreciation | 1414.20 | 1400.50 | 0.98 | 1414.20 | 1400.50 | 0.98 | 7247.50 | 5483.40 | 32.17 |
| PBT | 10829.20 | 5765.30 | 87.83 | 10829.20 | 5765.30 | 87.83 | 27846.90 | 5271.40 | 428.26 |
| TAX | 1937.40 | 995.70 | 94.58 | 1937.40 | 995.70 | 94.58 | 4586.00 | 1019.30 | 349.92 |
| Deferred Tax | 45.50 | -11.50 | -495.65 | 45.50 | -11.50 | -495.65 | -254.50 | 60.40 | -521.36 |
| PAT | 8891.80 | 4769.60 | 86.43 | 8891.80 | 4769.60 | 86.43 | 23260.90 | 4252.10 | 447.04 |
| Equity | 911.90 | 910.20 | 0.19 | 911.90 | 910.20 | 0.19 | 911.40 | 910.00 | 0.15 |
| PBIDTM(%) | 29.70 | 20.96 | 41.70 | 29.70 | 20.96 | 41.70 | 24.31 | 10.43 | 133.18 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1872.40 |
| Dr. Reddys Lab | 1279.70 |
| Cipla | 1304.70 |
| Zydus Lifesciences | 956.65 |
| Lupin | 2245.65 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: